NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled
NCT02273739 2021-02-23Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCelgenePhase 1/2 Completed21 enrolled 33 charts
NCT03941626 2021-02-04Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown50 enrolled
NCT02713984 2020-03-19A Clinical Research of CAR T Cells Targeting HER2 Positive CancerSouthwest Hospital, ChinaPhase 1/2 Withdrawn
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled